While these studies did not investigate systemic tenascin-C, the data presented above for the FNIII-C ELISA found that control and RA patients had lower average systemic tenascin-C concentrations of 25.7 and 77.3ng/ml, respectively. Here, TNC is linked to rheumatoid arthritis.